Abstract:Objective To detect the expression of peripheral blood free prostate specific antigen (fSPA),total prostate specific antigen (tSPA),prostate specific antigen density (PSAD) and prostate cancer gene 3 (PCA3) in prostate disease,and the significance of combined detection of fSPA,tSPA and PCA3.Methods 67 patients with prostate cancer,75 patients with prostatic hyperplasia and 70 healthy male were selected as the research objects from Dec.2014 to Jul.2016.The serum level of fSPA and tSPA was detected by chemiluminescence immune staining method.The prostate volume was tested by ultrasonic sound and PSAD value was calculated.The total RNA was extracted by Trizol,and the serum PCA3 mRNA expression was detected by RT-PCR.The specificity and sensitivity of combined detection of fSPA,tSPA and PCA3 were analyzed.Results The serum levels of fSPA,tSPA,PSAD and PCA3 in prostate cancer were significantly higher than those in patients with prostatic hyperplasia and healthy male,and they were higher in patients with hyperplasia of prostate than in healthy male,and the differences had statistical significance (P＜0.01).The serum levels of fSPA,tSPA,PSAD and PCA3 were higher in patients with Gleason score ≥7 points and in T3-T4 stage than in patients with Gleason score ＜7 and in T1-T2 stage,and the difference had statistical significance (P＜0.01).The serum levels of fSPA,tSPA,PSAD and PCA3 were positively correlated with Gleason score and TMN pathological stage,and the difference had statistical significance (P＜0.01).The AUC value of fSPA,tSPA,PSAD and PCA3 in diagnosis of prostate cancer was 0.53,0.57,0.63 and 0.75,and the AUC value of combined detection was 0.92.The combined detection efficiency was higher than the single index.The specificity of fSPA,tSPA,PSAD and PCA3 was 67.16％,68.66％,73.13％ and 85.07％,and the sensitivity was 71.64％,70.15％,74.63％ and 82.09％ respectively.The specificity of combined detection was 97.01％,the sensitivity was 92.54％,and the difference had statistical significance (P＜0.01).Conclusion The serum level of fSPA,tSPA,PSAD and PCA3 is increased in prostate disease,and is negatively correlated with Gleason score and TMN pathological stage.The combined detection of fSPA,tSPA,PSAD and PCA3 can improve the sensitivity and specificity of prostate disease diagnosis,and is of high clinical value.

The Clinical Value of the Combined Measurement of Three Serum Tumor Markers in Breast Cancer

Clinical significance of five serum markers in diagnosis of breast cancer

Applied Research of Prostate Specific Antigen Combined with Prostate Cancer Gene 3 in Diagnosis of Prostate Disease

Clinical Value of Serum Marker Detection for Breast Cancer at Ⅲ, Ⅳ Stages and During Postoperative Follow-Up

The Expression Leuel of CA15-3 and TPS of Patient with Mamumary Cancer and its Clinical Value

Clinical Value of Detecting Serum Tumor Markers in Postoperative Breast Cancer Patients

The role of CA153,CA125,HER-2 combined detection for the diagnosis of breast cancer

Diagnostic value of combination detection of CA125 and CA153 in breast cancer

Clinical analysis of TSGF, CA15-3 and CEA in diagnosis of breast neoplasm

Clinical Significance of Combined Detection of Serum Tumor Markers in Diagnosis of Patients with Ovarian Cancer.

A Study the Clinical Value of Combined Detection of Serum CEA CA199 and CA125 in Patient with Lung Cancer

Diagnostic Value of Combined Determination of Serum CEA,CA125 and CA724 Levels in Patients with Ovarian Cancer

Diagnostic Value of Total Prostate Specifc Antigen (TPSA) in Women with Breast Cancer in the Molecular Subtyping Era.

Combining multiple serum biomarkers in tumor diagnosis: A clinical assessment.

Clinical Usefulness of Serum Tumor markers CEA, CA19-9 and CA72-4 in Colorectal Cancer Diagnosis

The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer

The value of serum HE4 and CA1 53 in the early diagnosis of breast cancer

The Clinical Application Value of Combined Detection of Tumor Markers CEA、CA199、CA125 and CA724 in Gastric Cancer

Evaluation of clinical value of combined tumor markers detection in diagnosis of lung cancer

DIAGNOSTIC VALUE OF SERUM TUMOR MARKERS FOR LUNG CANCER

Diagnostic value of combined measurement of serum ULBP-2 and MIC-1 for pancreatic cancer